There were an estimated 66,730 serious antibiotic-resistant infections in 2023. National surveillance data published by the UK Health Security Agency ...

This is not my mom,” Tank said. Tank said she received devastating news. “She was off the charts with urosepsis, and there ...

urosepsis, incontinence or a ≥1.5 mg/dl increase in serum creatinine level or to a value ≥50% above baseline. At 1 year there was little difference between the doxazosin and combination groups ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

It can lead to urosepsis (up to 30% of all urosepsis cases start in the urinary tract). Despite that risk, I was dismissed for years by medical professionals who suggested that I was wrong about ...

After initiating, monitor for signs and symptoms of volume depletion and renal function. Urosepsis and Pyelonephritis Serious urinary tract infections including urosepsis and pyelonephritis ...

Urosepsis and Pyelonephritis: Treatment with SGLT2 inhibitors, including INPEFA, increases the risk for urinary tract infections. Serious urinary tract infections including urosepsis and ...

In the treatment arm of part two, serious adverse events led two patients to discontinue therapy: one patient had recurrent urosepsis and the other had an episode of vertigo accompanied by acute ...

This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and Europe Completed ZYNQUISTA FDA Advisory Committee Meeting; PDUFA Goal Date December 20, 20 ...